Summary:
Click image to enlarge
We are looking for adults with Type 2 Diabetes to take part in the AWARD-10 clinical research study.
We'll be asking whether adding a GLP-1 receptor agonist to SGLT2 inhibitors can improve blood sugar control.
Qualified Participants Must:
• Be struggling to control your Type 2 Diabetes
•
Be taking an SGLT2 Inhibitor (such as Empagliflozin, Dapagliflozin, or Canagliflozin)
•
Not be taking any other Diabetes medications (except Metformin)
•
Be 18 years of age or older
Qualified Participants May Receive:
Travel Compensation may be available.